4
Changes in Ownership
ArriVent BioPharma, Inc. Filed Acc 0001104659-24-008796
Director bought 444,444 shares at $18.00 ($7,999,992)
- Director acquired 1,252,308 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HEALY JAMES Director | 2024-01-30 | Conversion | +1,252,308 | 1,252,308 | I: show line 1 in the form | ||
| HEALY JAMES Director | 2024-01-30 | Purchase | +444,444 | $18.00 | $7,999,992 | 1,696,752 | I: show line 2 in the form |
| Open-market purchases · 444,444 sh · avg $18.00 · $7,999,992 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HEALY JAMES Director | 2024-01-30 | Conversion · Series B Preferred Stock | −1,252,308 | 0 | I: show line 3 in the form |
Loading xslF345X05/tm244611-2_4seq1.xml…